ADXN
ADXN: Dyer Timothy Mark discloses securities transactions
Dyer Timothy Mark reported Grant or award in Addex Therapeutics Ltd.: 18857075 units of Stock-option (Right to Buy) (derivative), dated 2026-11-11. The full Form 4 contains 1 transaction entry.